Analyst Reco. OmniAb, Inc.

Equities

OABI

US68218J1034

Market Closed - Nasdaq Other stock markets 21:00:00 25/06/2024 BST			5-day change	1st Jan Change
3.79 ^USD	-6.65%		-9.55%	-38.57%

05-29	Omniab Insider Bought Shares Worth $1,059,840, According to a Recent SEC Filing	MT
05-09	Earnings Flash (OABI) OMNIAB Reports Q1 Revenue $3.8M, vs. Street Est of $5.9M	MT

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Omniab Insider Bought Shares Worth $1,059,840, According to a Recent SEC Filing	05-28	MT
OmniAb Insider Bought Shares Worth $1,167,750, According to a Recent SEC Filing	03-25	MT
RBC Initiates OmniAb at Outperform With $6 Price Target, Says Stock Gives Exposure to Growth Potential of Monoclonal Antibody Therapies	11-29	MT
Benchmark Initiates OmniAb at Buy With $8 Price Target	21/04/23	MT
Craig-Hallum Initiates OmniAb at Buy Rating With $10 Price Target	13/04/23	MT
Cowen Initiates OmniAb at Outperform With $10 Price Target	22/02/23	MT
HC Wainwright Starts OmniAb at Buy With $11 Price Target	13/02/23	MT
Truist Starts OmniAb at Buy With $10 Price Target	20/12/22	MT
Credit Suisse Initiates OmniAb at Outperform Rating With $13 Price Target	16/12/22	MT
SVB Securities Starts OmniAb at Outperform With $6 Price Target	29/11/22	MT
Stifel Starts OmniAb at Buy With $12 Price Target	28/11/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer